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Abstract Among the composite materials, ceramic/
polymer possesses significant advantages of high mechan-
ical reliability and excellent biocompatibility for applica-
tions in load-bearing areas. In this work, PVPCS(Poly
(4-vinyl pyridine-co-styrene))/FHAp nanocomposites of
varying weight percentages were synthesized and charac-
terized physical-chemically by XRD, FTIR, 31P NMR,
TGA, DTA, and FE-SEM and biologically by antimicrobial
and anti-inflammatory assays for evaluating their potential
use for biomedical applications. The results indicated that
the size and crystallinity of FHAp nanoparticles decrease
with increase in PVPCS concentration in the composite.
SEM confirmed the presence of FHAp nano rod crystals in
PVPCS matrix. The nano PVPCS20/FHAp demonstrated
the highest antifungal and antibacterial activity and favor-
able inhibition of human cell hemolysis. The designed
PVPCS/FHAp nanocomposites constitute promising can-
didates for biomedical applications.
Keywords Fluorinated hydroxyapatite 
Nanocrystalline  Nanocomposite 
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Introduction
The past three decades have witnessed a significative
increase in the use of biomaterials for bone-related surgical
applications. In certain applications involving artificial
bones and teeth, the thrust for high biocompatibility, bio-
activity, ability for biodegradation, and mechanical prop-
erties equivalent to bone and teeth is ensured from the
clinical experience. However, the biodegradation of HAp
under physiological conditions makes the interface
between HAp and bone unstable (Bertinetti et al. 2007).
Fluoridated hydroxyapatite (FHAp), where F- partially
replaces the OH- in the hydroxyapatite, is considered as an
alternative material for bone repair due to its low solubility
and good biocompatibility (Boissiere et al. 2006; Bose and
Saha 2003; Chen et al. 2004). Many researchers have also
demonstrated that fluoride ions in the culture medium
stimulated osteoblastic activities in terms of cell prolifer-
ation and differentiation (Chen et al. 2007; Choi and
Kumta 2006; Darder et al. 2006; Degirmenbasi et al. 2006).
The amount of fluoride ions released from fluoridated
hydroxyapatite (FHAp) could be controlled by tailoring the
fluoride content in FHAp (Ding et al. 2007). The higher the
level of fluoridation, the more fluoride ions released. As a
result, besides its high thermal and chemical stability
(Boissiere et al. 2006; Gandhidasan et al. 1991), FHAp is
considered as a promising implant material due to its great
biological potential (Huang et al. 2007). However, high F-
concentration in bone can also lead to severe adverse
effects such as osteomalacia (Joseph and Tanner 2005).
Therefore, it is necessary to optimize the F- content in
fluoride-substituted hydroxyapatite so as to achieve the
maximum bioactivity of the material. However, the pure
FHAp is only suitable to the repair of non-load bearing
bones because of its fragility, low mechanical strength,
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easy rupturing, and weak fatigue resistance. On the other
hand, pure FHAp could not degrade in the human body.
These disadvantages of FHAp ceramic impede its further
clinical application. Accordingly, an ideal material was
needed to toughen the FHAp ceramic to better meet the
clinical demands in both biological characteristics and
mechanical properties. To solve the problem, incorporation
of FHAp into polymer matrix has been carried out to
increase osteoconductivity and biodegradability with sig-
nificant enhancement of mechanical strength. Poly-4-vinyl
pyridine-co-styrene (PVPCS) can be utilized in combina-
tion with FHAp to meet these requirements.
An extensive study has been made on both natural
(collagen, gelatin, silk fibroin) and synthetic (polyethylene,
polyamide, chitosan, polystyrene, poly(vinyl alcohol),
poly(ethylene glycol) and poly(etheretherketone) polymers
to overcome the mechanical problems associated with bio
ceramics in bone tissue engineering applications (Joseph
and Tanner 2005; Kannan and Ferreira 2006; Kannan et al.
2006; Kawagoe et al. 2000). Among the abovementioned
polymers, PVPCS remains one of the widely used polymer
group of biomaterials applied to medical implants. This
wide range of versatility is utilized in terms of tailoring their
applications such as tissue scaffolding (Kokubo and
Takadama 2006), artificial cartilage (Komlev et al. 2003),
and biodegradable scaffolds (Lak et al. 2008; Li et al. 2008,
2009). With the superior combination of the synergic effect
and biocompatible FHAp and the adjustable biodegrad-
ability of polymer matrix, FHAp nano rod embedded
PVPCS composites were prepared under controlled envi-
ronment. The present work carried out elaborates on syn-
thesis of nanostructured FHAp by wet chemical method
using calcium hydroxide, ammonium fluoride, and diam-
monium hydrogen phosphate as starting materials and
synthesis of nanostructured PVPCS/FHAp composite by
freeze-drying method using synthetic nano FHAp as start-
ing materials with the aid of PVPCS. In this paper PVPCS/
FHAp nanocomposites of varying compositions were pre-
pared. While the previously studied supports offer several
advantages, fluorinated hydroxyapatite is unique in its
bioactivity. In the present work we tried to synthesize,
characterize, and evaluate the invitro study of antimicrobial
and anti-inflammatory effect of the PVPCS/FHAp nano-
composite materials (Magaldi et al. 2004).
Experimental design
Materials
The raw materials required to start the processing of the
composite were analytical grade calcium hydroxide
[Ca(OH)2], ammonium fluoride and diammonium hydrogen
phosphate [(NH4)2HPO4] obtained from Merck (India), and
PVPCS purchased from Loba (India). Doubly distilled water
was used as the solvent.
Methods
Synthesis of nano FHAp
A 0.25-M ammonium fluoride solution and 0.3 M diam-
monium hydrogen phosphate (Merck India) solution were
prepared separately and these two solutions were added to
a 0.3-M calcium hydroxide aqueous suspension and stirred
vigorously. These reactants in aqueous medium with a pH
of 11 were immediately subjected to microwave irradiation
for about 30 min in a domestic microwave oven (Samsung,
1100 W power). The precipitate was thoroughly washed
with distilled water to remove impure ions (NH4
?). The
product obtained after filtration was oven-dried overnight
at 90 C and the flakes were powdered using an agate
mortar and pestle.
Synthesis of PVPCS/FHAp nanocomposites
The PVPCS/FHAp nanocomposites were coded as nano
PVPCS20/FHAp, nano PVPCS40/FHAp, nano PVPCS60/
FHAp, and nano PVPCS80/FHAp where number denotes
the wt % of PVPCS matrix used in the processing. Water
was used as the solvent to prepare the polymer solution.
PVPCS was dissolved using magnetic stirrer for 3 h and the
polymer solution was left overnight in room temperature to
remove the air bubbles trapped in the viscous solution. Then
suitable amount of FHAp was dispersed in deionised water
by 30-min ultrasonication (METAL POWER ANALYTI-
CAL (I) PVT. LTD. Maharashtra, India). Ultrasonication
was necessary to avoid agglomeration of ceramic powder
and to achieve proper dispersion. FHAp in water was mixed
with polymer solution under agitation. The homogeneously
mixed solution is immediately taken to deep freeze (AC
MAS Technology (p) Ltd,India) at -18 C. After 48 h of
freezing the samples were freeze dried.
Physical–chemical characterization
The prepared samples were studied by Fourier Transform
Infrared Spectroscopy (FTIR) using a Schimadzu FT-IR
300 series instrument (Shimadzu Scientific Instruments,
USA). The FTIR spectra were obtained over the region
450–4,000 cm-1 in pellet form for 1 mg powder samples
mixed with 200 mg spectroscopic grade KBr (Merck,
India). Spectra were recorded at 4 cm-1 resolution aver-
aging 80 scans. The structure of the samples was analyzed
by X-Ray Diffraction (XRD) using a Rich Siefert 3000
diffractometer (Seifert, Germany) with Cu-Ka1 radiation
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(k = 1.5418 A˚). The diffraction peak at 25.9 was chosen
for calculation of the crystallite size by Scherrer’s formula
since it is sharper and isolated from others. This peak
assigns to (002) Miller’s plane family and shows the crystal
growth along the axis of FHAp crystalline structure. The
morphology of the materials was analyzed by Field-
Emission Scanning Electron Microscopy (FE-SEM) using
a HITACHI S600N scanning electron microscopy (HIT-
ACHI High Tech, Japan). For the elemental analysis the
electron microscope was equipped with an energy-disper-
sive X-ray attachment (EDAX). Thermo gravimetric
analysis (TGA) coupled with differential thermal analysis
(DTA) of the material was performed (STA 1500, PL
Thermal Science,) between 35 and 1,400 C in air at a
heating rate of 20 K per minute to monitor the weight loss
of organic residues. 31P-MAS-NMR spectra were recorded
on a Bruker MSL 300 spectrometer (HORIBA Scientific
USA) equipped with an Andrew type rotor rotating at a
frequency of 10 kHz.
Antimicrobial characterization
For inoculum preparation, human pathogenic fungi from
American Type Culture Collection (ATCC, USA), Can-
dida albicans (ATCC 90028), and Candida paratrophicalis
(ATCC 42618) were used in the antifungal activity test. In
the antibacterial susceptibility test, fresh bacterial colonies
from ATCC (USA) of the five pathogenic strains (Staph-
ylococcus aureus [ATCC 12600], Escherichia coli [ATCC
11775], Salmonella typi [ATCC 700931], Vibrio cholerae
[ATCC 39315], and Klebsiella pneumonia [ATCC 13883])
were inoculated to Tryptic soy or Brain Heart Infusion
broth (EMD chemicals USA) and incubated at 37 C dur-
ing a time period of 22–24 h. Turbidity was adjusted with
sterile broth so as to correspond to the Mc Farland 0.5
barium sulfate method, where the standard equivalent to
1.5 9 106 Colony Forming Units (CFU)/ml in a 1:100
dilution of a suspension of turbidity. This is prepared
by adding 0.5 ml of 1.175 %w/v (0.048 m) hydrate
(BaCl22H2O) to 99.5 ml of 1 % w/v (0.36) sulfuric acid
(Merk, India).
Antifungal and antibacterial activities of the PVPCS/
FHAp nanocomposites were tested by the well diffusion
method using Sabouraud dextrose agar and Muller Hinton
agar (Sigma Aldrich, India). The radial growth of the
colony was analyzed on completion of the incubation, and
the mean diameter for each composite at concentrations of
250, 500, 750, and 1,000 lg/ml were recorded. The aver-
age percentage inhibition of the bacterial growth medium
was compared using the Vincent equation I = 100/(C-T)/
C, where I = percentage inhibition, T = average diameter
of the bacterial growth on the tested plates, and
C = average diameter of the growth on the control plates.
Stock solutions of tested compounds were prepared in
dimethyl sulfoxide (Sigma-Aldrich, India).
Anti-inflammatory activity test by HRBC membrane
stabilization method
The human red blood cell (HRBC) membrane stabilization
has been used as method to study the anti-inflammatory
activity. After approbation of Human Research Ethics
Committee and signed consent form, blood samples col-
lected from healthy volunteer were used in this test. The
harvested blood was mixed with equal volume of sterilized
Alsever solution (2 % dextrose, 0.8 % sodium citrate,
0.05 % citric acid and 0.42 % sodium chloride in water).
The blood was centrifuged at 3,000 rpm and packed cell
were washed with isosaline (0.85 %, pH 7.2) and a 10 %
(v/v) suspension was made with isosaline. The assay
mixture contained the drug (various concentrations g/ml),
1 ml of phosphate buffer (0.15 M, pH 7.4), 2 ml of hy-
posaline (0.36 %), and 0.5 ml of HRBC suspension. Dic-
lofenac (Sigma Aldrich, India) was used as reference drug.
Instead of hyposaline 2 ml of distilled water was used in
the control. All the assay mixture was incubated at 37 C
for 30 min and centrifuged. The hemoglobin content in the
supernatant solution was estimated using spectrophotome-
ter at 560 nm (Shimadzu Scientific Instruments, USA). The
percentage protection was calculated by assuming the
hemolysis produced in the presence of distilled water to be
100 %. The percentage of hemolysis was calculated using
the following formula:
%Protection¼ 100Optical density of drug treated sample




The XRD patterns of nano FHAp and nano PVPCS/FHAp
composites were taken. The patterns indicate the presence
of amorphous FHAp. The broad peaks reveal that the
particles sizes are very small in the range of 35–50 nm.
The reflection planes corresponding to the characteristic
XRD spectral peaks of pure nanoHAp and PVPCS/FHAp
nanocomposites are shown in Fig. 1. The observed dif-
fraction peaks are identified by standard JCPDS file (no.
87-2462) and are assigned as crystalline FHAp. The sharp
diffraction characteristic peaks that appeared at around 29
and 47 are the PVPCS/FHAp nanocomposites corre-
sponding to the peaks of FHAp powder. The XRD patterns
show diffraction peaks with high intensities, which con-
firms the nano size with crystalline nature (Meenakshi
Appl Nanosci (2013) 3:373–382 375
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Sundaram et al. 2006; Murugan and Ramakrishna 2004;
Neira et al. 2009).
FTIR analysis
The FTIR spectra of pure nano FHAp and PVPCS/FHAp
nanocomposites are shown in Fig. 2. The m2 phosphate
stretching mode appeared at 465–486 cm-1 and corre-
sponds to PO4
3- group in FHAp (Degirmenbasi et al.
2006). The bands that appeared at 1,042–1,070 cm-1 and
565–567 cm-1 correspond to different modes of the PO4
3-
group in fluorinated hydroxyapatite (Yanbao et al. 2008).
The band that appeared at 604 cm-1 corresponds to O–P–
O bending and m1 symmetric P–O stretching modes (Ma
et al. 2006). The m1 symmetric stretching mode of phos-
phate group is observed at 882 cm-1 (Zhang and Mild
2008). The observed band at 1,367 cm-1 is due to the
stretching mode of carbonate, which may be due to the
acquisition of air during mineral precipitation (Bertinetti
et al. 2007). Similarly, the observed bands at 1,417 and
823–882 cm-1 are assigned to carbonate ions (Pan and
Xiong 2009; Paulo et al. 2011; Pramanik et al. 2006, 2008).
The lattice H2O exists in the range of 1,599–1,602 cm
-1,
while the bands observed at 3,411–3,432 cm-1 overlap the
–OH group (Kannan and Ferreira 2006). The band
observed between 2,926 and 2,929 cm-1 corresponds to C–
H stretching band of PVPCS (Murugan and Ramakrishna
2004). A new peak of stretching band is observed at
2,929 cm-1, when the PVPCS is added. This indicates the
chemical bond interactions between FHAp and PVPCS. A
new peak band that appears at 1,219–1,220 cm-1 corre-
sponds to F- group in FHAp. The bands observed between
1,638 and 1,710 cm-1 and 1,270 and 1,271 cm-1 corre-
spond to C=N stretching band and C–N band of PVPCS
(Murugan and Ramakrishna 2004).
FE-SEM analysis
SEM images of pure nano FHAp and different weight
percentages of PVPCS compositions are illustrated in
Fig. 3. The SEM picture shows that particles exhibit nano
rod morphology. The particle size of pure FHAp is in the
range of 27–70 nm. In case of composites, when the
composition of PVPCS is added to FHAp, the rod-like
morphology starts to disappear. The increase in the PVPCS
compositions, i.e., 20, 40, 60 wt. % leads to a corre-
sponding change from rod-like to an irregular morphology.
Further, it is evident that the particle size decreases with
Fig. 1 XRD Pattern of a nano FHAp, b nano PVPCS20/FHAp,
c nano PVPCS40/FHAp, d nano PVPCS60/FHAp and e nano
PVPCS80/FHAp and f PVPCS
Fig. 2 FT-IR Spectra of a nano FHAp, b nano PVPCS20/FHAp,
c nano PVPCS40/FHAp, d nano PVPCS60/FHAp and e nano
PVPCS80/FHAp and f PVPCS
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increase in PVPCS composition. The elemental analysis
(EDAX) of nano PVPCS20/FHAp and nano PVPCS60/
FHAp can demonstrate similar composition as illustrated in
Fig. 4. Mineral composition (calcium phosphate: Ca, O, P)
and organic content (C) are present in both nanocomposites
tested.
HRTEM analysis
Figure 5 shows the TEM photograph of nano PVPCS/
FHAp composite powder. The nano PVPCS/FHAp com-
posite particles, shown in Fig. 5 are in nanometer scale.
Nano PVPCS/FHAp composite particles were a bit thicker
(10–60 nm) and longer with clear contour. In addition the
particles showed less agglomeration, and the selected area
electron diffraction (SAED, in Fig. 5) of the precipitates
shows diffraction ring or patterns, which implies that the
precipitates are crystalline. This agrees with XRD results.
Thermo gravimetric analysis
The TGA (Fig. 6) of the PVPCS/FHAp nanocomposite
powder was carried out between 50 and 1,400 C in air at a
heating rate of 20 C/min. The decomposition behavior of
Fig. 3 FE-SEM images of a nano FHAp, b nano PVPCS20/FHAp, c nano PVPCS40/FHAp and d nano PVPCS60/FHAp
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PVPCS/FHAp nanocomposite is shown in Fig. 6. The nano
FHAp content is calculated from the residual weight in
TGA curves at 600 C. However, since it is very difficult to
control adsorbed water content in the composites, this nano
FHAp content is only an approximate value. In the TGA
curves several steps are observed (Rajendran et al. 2002;
Singh et al. 2008; Wang et al. 2007). The first step,
showing a small decrease in weight, is associated with
adsorbed water-removing when heated above 90 C. The
second step from 140 to 390 C may be due to the dehy-
dration reaction of C–OH groups in PVPCS chains. This
temperature shifts to a higher temperature, when the nano
FHAp content increases. The third step was degradation of
PVPCS matrix releasing CO2 gas. This temperature shifts
to a lower temperature in the TG curves caused by the
increasing nano FHAp content. The fact that the second
step is initiated at slightly higher temperature and the third
step occurs at slightly lower temperature than in pure
PVPCS is suggestive of the presence of chemical interac-
tion between PVPCS and the nano FHAp.
31P MAS-NMR analysis
The 31P MAS-NMR spectra for the PVPCS/FHAp nano-
composite and nano FHAp powders are shown in Fig. 7. A
distinctive resonance peak appears at 0.050 ppm in Fig. 7
for the nano FHAp (Zhan et al. 2005; Zhang and Mild
2008; Zhang et al. 2003). After the development of
PVPCS/FHAp nanocomposites, the 31P characteristic peak
moves to 1.902 ppm as shown in Fig. 7a, indicating that
after the formation of nanocomposites, the chemical envi-
ronment of the phosphorus atom in nano FHAp crystal has
been changed. This shift is due to the interaction of FHAp
with PVPCS in PVPCS/FHAp nanocomposite. The chem-
ical interaction may be due the hydrogen bonding inter-
action between the PO4
3- ions of FHAp and the –OH
functional groups of PVPCS.
Antimicrobial analysis
The antifungal activity of the screening data for the com-
posites are given in Table 1. It is observed from the results
that PVPCS/FHAp nanocomposites show some antifungal
activity. However, the PVPCS20/FHAp nanocomposite
showed higher activity against the tested fungus at 1,000 lg/
ml concentration and other inoculums dilutions when com-
pared with the other PVPCS/FHAp nanocomposite.
When the antibacterial activity was evaluated as
shown in Table 1, all the PVPCS/FHAp composition of
Fig. 4 EDAX Spectrum of
nano PVPCS60/FHAp
Fig. 5 HR TEM and SAED images of FHAp-PVPCS 20 nanocomposite
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nanocomposites showed comparable activity against all the
selected bacteria. From the data it is observed that at
1,000 lg/ml concentration, the composite of PVPCS40/
FHAp showed higher antibacterial activity against Salmo-
nella typhi, Vibrio cholera, Escherichia coli, and Klebsiella
pneumoniae. PVPCS20/FHAp showed higher antibacterial
activity against Staphylococcus aureus. The antibacterial
activity is dependent on the molecular structure of the
compound, the solvent used, and the bacterial stain under
consideration.
Anti-inflammatory potential analysis
The compound PVPCS20/FHAp and PVPCS 60/FHAp
showed significant protection against HRBC membrane
rupture which is induced by hypotonic saline (Wang et al.
2008; Wiria et al. 2008; Yang et al. 1997; Yanbao et al.
2008; OECD). The effect may be due to the resistance
caused by polymers in the destruction of erythrocyte
membrane. From the results it was proved that nano
PVPCS20/FHAp composition was more effective than
Fig. 6 TGA curve of nano
PVPCS20/FHAp composite
Fig. 7 31P MAS-NMR Spectra of nano FHAp and (7a) 31P MAS-NMR Spectra of nano PVPCS40/FHAp composite
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nano PVPCS60/FHAp composition and also nano FHAp
(Fig. 8; Table 2). Further work is in progress to identify the
exact mechanism involved in anti inflammatory activity.
Developing a biomaterial with good mechanical and bio-
logical properties and with perspective to act as a cell
carrier of stem cells or differentiated cells is a challenge in
regenerative medicine.
Evaluation of in vivo anti-inflammatory activity
of PVPCS 40/nanoFHAp composite
Determination of lethal dose-50
The median lethal dose LD50 of the chemical compound
was determined in male wistar rats using oral administra-
tion of PVPCS40/nano FHAp. The experiment was carried
out in five groups for PVPCS40/nano FHAp composite of
three animals per each group that were administered 100,
250, 500, 1,000, 2,000 mg/kg of extract respectively.
The animals were monitored for about 24 h and fol-
lowing parameters are noted in each group
1. Body weight
2. Any changes in skin, eyes
3. Somatomotor activity
Behavior patterns such as tremor, rigidity, convulsions,
salivations, diarrhea, lethargy, sleep and coma.
There was no toxicity actions observed while examining
the above parameters.
In vivo anti-inflammatory activity using sample-I (PVPCS
40/nanoFHAp) with carrageenan induced paw oedema
in rat models
The mercury displacement method was used to determine
the anti-inflammatory activity against carrageenan-induced
paw odema. The animals were divided into four groups
comprising six animals in each group.
The control groups were treated with carrageenan
0.1 %,the second group were treated with indomethacin
20 mg/kg i.p ? carrageenan, and the third and fourth
groups were treated with PVPCS 40/nano FHAp composite
125 mg/kg and 250 mg/kg ? carrageenan Table 3.
Table 1 Antibacterial and antifungal activity of nano PVPCS/FHAp composites
Organism Sample name









Concentration (in lg/ml) Concentration (in lg/ml) Concentration (in lg/ml) Concentration (in lg/ml)
500 750 1000 500 750 1000 500 750 1000 500 750 1000
S. aureus 11 12 13 11 11 11 11 11 11 – – –
S. typi – 11 12 13 14 15 12 13 13 13 14 14
E. coli – 11 12 13 13 14 11 13 14 11 12 13
V. cholerae 11 12 11 11 12 14 – – 11 11 12 –
K. pneumoniae – 12 12 11 15 17 12 11 11 – 12 15
C. albicans 11 12 13 – 11 12 – 11 12 11 11 12
C. paratrophicalis 11 12 12 – 11 12 – 11 11 – 11 11
Fig. 8 Anti-inflammatory study of FHAp and PVPCS/FHAp
nanocomposites













10 99.25 99.52 94.94
50 98.72 98.16 98.72
100 98.63 99.34 99.54
200 98.57 99.90 99.33
400 98.67 99.85 98.45
800 98.23 99.12 99.41
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Conclusions
In the present work, a novel PVPCS/FHAp nanocomposite
is prepared by simple chemical route. The reduction in
particle size with increase in concentration of PVPCS is due
to the size control effect of PVPCS molecular structure. The
rod-like morphology becomes as an irregular morphology
with increase in PVPCS additives. It is inferred that the
composition of PVPCS shows significant influence on
particle size, thermal stability, and antimicrobial activities
which facilitate to optimize the composition of composite
for particular applications. Nanomaterials are greatly
promising in the development of more valuable orthopedic
and dental implants. However, the mechanism of interac-
tion between PVPCS/nano FHAp and biologic systems
should be investigated thoroughly in future and applied in
studies using in vitro, in vivo and preclinical methodologies
to validate its use for biomedical applications.
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